Insider Transactions Reported by 16 Insiders of UroGen Pharma Ltd.

Symbol
URGN on Nasdaq
Location
Ra'anana, Israel

Insiders trading volume in the past year

UroGen Pharma Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ran Nussbaum Director $26,747,876 21 Oct 2022
Mark Schoenberg Chief Medical Officer $3,475,625 -$630,839 -15.4% 19 Nov 2025
Jason D. Smith General Counsel $827,558 -$255,220 -23.6% 07 Sep 2025
Dong Kim Chief Financial Officer $493,809 09 Sep 2024
Molly Henderson Chief Financial Officer $94,516 31 Jan 2022
Stuart Holden Director $39,560 26 Nov 2025
LEANA WEN Director $39,560 26 Nov 2025
James A. Robinson Jr. Director $39,560 26 Nov 2025
Daniel George Wildman Director $39,560 26 Nov 2025
CYNTHIA M. BUTITTA Director $39,560 26 Nov 2025
Chris Degnan Chief Financial Officer $38,418 -$37,121 -49.1% 08 Oct 2025
Elizabeth Barrett Chief Executive Officer 28 Jul 2025
Arie Belldegrun Director 26 Aug 2025
Fred E. Cohen Director 06 Aug 2024
KATHRYN E. FALBERG Director 07 Jun 2021
Shawn Tomasello Director 07 Jun 2021

Recent Insider Transactions by Companies or Individuals for UroGen Pharma Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.